Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 64228-79-1
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of atracurium during breastfeeding. Because it is short acting, highly polar and poorly absorbed orally, it is not likely to reach the breastmilk in high concentration or to reach the bloodstream of the infant.[1,2] When a combination of anesthetic agents is used for a procedure, follow the recommendations for the most problematic medication used during the procedure. Consider using an atracurium product that has no benzyl alcohol preservative.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Spigset O. Anaesthetic agents and excretion in breast milk. Acta Anaesthesiol Scand. 1994;38:94–103. [PubMed: 8171959]
- 2.
- Dalal PG, Bosak J, Berlin C. Safety of the breast-feeding infant after maternal anesthesia. Paediatr Anaesth. 2014;24:359–71. [PubMed: 24372776]
Substance Identification
Substance Name
Atracurium
CAS Registry Number
64228-81-5; 64228-79-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Muscle Relaxants
Neuromuscular Nondepolarizing Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Pancuronium.[Drugs and Lactation Database (...]Review Pancuronium.. Drugs and Lactation Database (LactMed®). 2006
- Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spectrometry.[Rapid Commun Mass Spectrom. 1995]Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spectrometry.Dear GJ, Harrelson JC, Jones AE, Johnson TE, Pleasance S. Rapid Commun Mass Spectrom. 1995; 9(14):1457-64.
- Review Metolazone.[Drugs and Lactation Database (...]Review Metolazone.. Drugs and Lactation Database (LactMed®). 2006
- Review Cisatracurium.[Drugs and Lactation Database (...]Review Cisatracurium.. Drugs and Lactation Database (LactMed®). 2006
- Review Iopromide.[Drugs and Lactation Database (...]Review Iopromide.. Drugs and Lactation Database (LactMed®). 2006
- Atracurium - Drugs and Lactation Database (LactMed®)Atracurium - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...